 |
The Journal of Neuroscience, October 11, 2006, 26(41):10577-10589; doi:10.1523/JNEUROSCI.1767-06.2006
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Dopaminergic Control of SleepWake States
Kafui Dzirasa,1
Sidarta Ribeiro,1
Rui Costa,1,6
Lucas M. Santos,1
Shih-Chieh Lin,1
Andres Grosmark,1
Tatyana D. Sotnikova,4
Raul R. Gainetdinov,4
Marc G. Caron,4 and
Miguel A. L. Nicolelis1,2,3,5
Departments of 1Neurobiology, 2Biomedical Engineering, 3Psychological and Brain Sciences, and 4Cell Biology and 5Center for Neuroengineering, Duke University Medical Center, Durham, North Carolina 27710, and 6Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892-9411
Correspondence should be addressed to Dr. Miguel A. L. Nicolelis, Department of Neurobiology, Duke University Medical Center, Bryan Research Building, Durham, NC 27710. Email: nicoleli{at}neuro.duke.edu
Dopamine depletion is involved in the pathophysiology of Parkinson's disease, whereas hyperdopaminergia may play a fundamental role in generating endophenotypes associated with schizophrenia. Sleep disturbances are known to occur in both schizophrenia and Parkinson's disease, suggesting that dopamine plays a role in regulating the sleepwake cycle. Here, we show that novelty-exposed hyperdopaminergic mice enter a novel awake state characterized by spectral patterns of hippocampal local field potentials that resemble electrophysiological activity observed during rapid-eye-movement (REM) sleep. Treatment with haloperidol, a D2 dopamine receptor antagonist, reduces this abnormal intrusion of REM-like activity during wakefulness. Conversely, mice acutely depleted of dopamine enter a different novel awake state characterized by spectral patterns of hippocampal local field potentials that resemble electrophysiological activity observed during slow-wave sleep (SWS). This dopamine-depleted state is marked by an apparent suppression of SWS and a complete suppression of REM sleep. Treatment with D2 (but not D1) dopamine receptor agonists recovers REM sleep in these mice. Altogether, these results indicate that dopamine regulates the generation of sleepwake states. We propose that psychosis and the sleep disturbances experienced by Parkinsonian patients result from dopamine-mediated disturbances of REM sleep.
Key words: dopamine; sleep; REM; psychosis; schizophrenia; Parkinson's
Received April 25, 2006;
revised Aug. 29, 2006;
accepted Aug. 29, 2006.
Correspondence should be addressed to Dr. Miguel A. L. Nicolelis, Department of Neurobiology, Duke University Medical Center, Bryan Research Building, Durham, NC 27710. Email: nicoleli{at}neuro.duke.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2006 26: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
N. D. Volkow, G.-J. Wang, F. Telang, J. S. Fowler, J. Logan, C. Wong, J. Ma, K. Pradhan, D. Tomasi, P. K. Thanos, et al.
Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain
J. Neurosci.,
August 20, 2008;
28(34):
8454 - 8461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Massicotte-Marquez, A. Decary, J-F Gagnon, M. Vendette, A. Mathieu, R. B. Postuma, J. Carrier, and J. Montplaisir
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder
Neurology,
April 8, 2008;
70(15):
1250 - 1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Thannickal, Y.-Y. Lai, and J. M. Siegel
Hypocretin (orexin) cell loss in Parkinson's disease
Brain,
June 1, 2007;
130(6):
1586 - 1595.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|